title: [Vascular depressions].
abstract: The notion of vascular depression (VD) includes depressive disorders resulting from organic cerebral lesions of vascular genesis. Two types of VD are distinguished: post-stroke VD (PSD) and VD proper (SDP). VD develops in case of clinically manifest (neurologic) lesions in cerebral vessels that simultaneously act as psychogenic (nosogenic) factors. SDP is associated with clinically latent vascular disorders ("silent" infarctions and white matter ischemia). VD is characterized by multiple phenomenological convergence of vascular signs and symptoms inherent in both PSD and SDP. Whatever the type of VDs, they are associated with frequent cognitive problems with a variety of dynamic patterns, viz. reversible, relatively stable, and progressing.
authors.forename: V A
authors.initials: VA
authors.lastname: Kontsevoĭ
authors.forename: A V
authors.initials: AV
authors.lastname: Medvedev
mesh_terms: D000223:Adaptation, Psychological; D000342:Affective Symptoms / Q000209:etiology / Q000503:physiopathology / Q000523:psychology; D058070:Asymptomatic Diseases; D001921:Brain / Q000098:blood supply / Q000473:pathology; D058443:Catastrophization / Q000209:etiology / Q000523:psychology; D002536:Cerebral Arteries / Q000473:pathology; D002561:Cerebrovascular Disorders / Q000150:complications / Q000473:pathology / Q000503:physiopathology / Q000523:psychology; D003866:Depressive Disorder / Q000209:etiology / Q000503:physiopathology / Q000523:psychology / Q000628:therapy; D003937:Diagnosis, Differential; D006801:Humans; D011379:Prognosis; D011613:Psychotherapy; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D020280:Sertraline / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline